Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1417421-99-8

3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1417421-99-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1417421-99-8 Structure

  • Basic information

    1. Product Name: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine
    2. Synonyms: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine;3-bromo-5-fluoro-1-(p-tolylsulfonyl)pyrrolo[2,3-b]pyridine;EOS-60354
    3. CAS NO:1417421-99-8
    4. Molecular Formula: C14H10BrFN2O2S
    5. Molecular Weight: 369.2088032
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1417421-99-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.73g/cm3 at 20℃
    6. Vapor Pressure: 0-0Pa at 20-25℃
    7. Refractive Index: N/A
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine(1417421-99-8)
    12. EPA Substance Registry System: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine(1417421-99-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1417421-99-8(Hazardous Substances Data)

1417421-99-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1417421-99-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,7,4,2 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1417421-99:
(9*1)+(8*4)+(7*1)+(6*7)+(5*4)+(4*2)+(3*1)+(2*9)+(1*9)=148
148 % 10 = 8
So 1417421-99-8 is a valid CAS Registry Number.

1417421-99-8Downstream Products

1417421-99-8Relevant articles and documents

ANTI-INFLUENZA VIRUS PYRIMIDINE DERIVATIVE

-

, (2021/02/05)

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

FORMULATIONS OF AZAINDOLE COMPOUNDS

-

, (2021/01/22)

The present invention relates to pharmaceutical compositions, each comprising a multitude of granules that make up an intragranular phase of the composition, wherein the granules are produced by fluid bed granulation and comprise a HCI salt of Compound (1

PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION

-

, (2020/02/16)

Provided herein are compounds of Formula A, B or C that can inhibit the replication of influenza viruses, reduce the amount of influenza viruses, and/or treat influenza.

Synthesis of Differentially Protected Azatryptophan Analogs via Pd2(dba)3/XPhos Catalyzed Negishi Coupling of N-Ts Azaindole Halides with Zinc Derivative from Fmoc-Protected tert-Butyl (R)-2-Amino-3-iodopropanoate

Nimje, Roshan Y.,Vytla, Devaiah,Kuppusamy, Prakasam,Velayuthaperumal, Rajeswari,Jarugu, Lokesh Babu,Reddy, China Anki,Chikkananjaiah, Nanjundaswamy Kanikahalli,Rampulla, Richard A.,Cavallaro, Cullen L.,Li, Jianqing,Mathur, Arvind,Gupta, Anuradha,Roy, Amrita

, p. 11519 - 11530 (2020/10/12)

Unnatural amino acids play an important role in peptide based drug discovery. Herein, we report a class of differentially protected azatryptophan derivatives synthesized from N-tosyl-3-haloazaindoles 1 and Fmoc-protected tert-butyl iodoalanine 2 via a Neg

Novel heterocyclic compounds and medicinal application of same as anti-influenza virus inhibitors

-

, (2019/03/10)

The invention provides heterocyclic compounds represented by a formula (I) as described in the specification or a pharmaceutically acceptable salt thereof, a preparation method thereof, and application of the heterocyclic compounds to the preparation of m

Heterocyclic compounds and, their compositions and their use as anti-influenza virus drugs (by machine translation)

-

, (2020/01/03)

The invention provides a class of heterocyclic (I) compounds or pharmaceutically acceptable salts thereof as shown in formula (I) or a preparation method thereof as well A as a preparation method and application of the compounds in. preparation of drugs for treating or, preventing influenza viruses RNA. (by machine translation)

Influenza virus replication inhibitors and uses thereof (by machine translation)

-

, (2019/10/01)

The invention provides a compound as an influenza virus replication inhibitor, a method for preparing the same, a pharmaceutical composition containing the compound and application. (by machine translation)

PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION

-

, (2018/11/22)

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient a safe and effective amount of a compound represented by any of Formulas l-lll, or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a safe and effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF

-

, (2018/03/25)

The invention provides a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the manufacture of medicaments for treating of influenza.

Influenza virus replication inhibitor and application thereof

-

, (2018/11/22)

The invention provides a type of compounds serving as an influenza virus replication inhibitor, a preparation method of the compounds, a pharmaceutical composition comprising the compounds, and application of the compounds and the pharmaceutical composition thereof in treatment of influenza.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1417421-99-8